Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2021

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Regains Full Compliance with Nasdaq Listing Requirements

Posted on January 6, 2021 by MissionIR

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced its receipt of notice from The Nasdaq Stock Market on Jan. 5, 2021, that VistaGen has regained compliance … Continue reading →

Posted in MissionIRNewsBreaks, VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in H.C. Wainwright BioConnect Virtual Conference

Posted on January 6, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that it will participate in the virtual H.C. Wainwright BioConnect Conference taking place on Jan. 11-14, 2021. According to the update, … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX | Leave a comment

MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Upcoming H.C. Wainwright Bioconnect Conference

Posted on January 6, 2021 by MissionIR

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at … Continue reading →

Posted in 180 Life Sciences Corp., MissionIRNewsBreaks | Leave a comment

Cybin Inc. (NEO: CYBN) R&D Sees Hope in Growing Acceptance of Psilocybin

Posted on January 5, 2021 by MissionIR

U.S. taking actionable steps toward acceptance of psilocybin States, individual cities have decriminalized, made use and possession of psilocybin low law-enforcement priority More psilocybin research being done focused on health, well-being of Americans facing a mental health crisis on epic … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Finalizes Chemours Monazite Supply Agreement, Marks Beginning of ‘Real Success Story’

Posted on January 5, 2021 by MissionIR

UUUU to receive minimum of 2,500 tons of natural monazite ore, one of highest-grade REE minerals in world Company to produce raw materials needed for clean energy, advanced technologies while also creating green jobs in economically underserved area Energy Fuels … Continue reading →

Posted in Energy Fuels Inc. UUUU | Leave a comment

MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Engages Investor Relations Firm

Posted on January 5, 2021 by MissionIR

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that it has hired an investor relations firm. POAI has chosen Landon Capital to provide investor relations services; the … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters into Agreement with Fortune 500 Subsidiary to Provide Digital Therapeutics Solution

Posted on January 5, 2021 by MissionIR

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has been selected by a subsidiary of a U.S.-based Fortune 500 technology and engineering company to provide its digital therapeutics solution to eligible employees. DarioHealth’s partnership with Vitality Group … Continue reading →

Posted in DarioHealth Corp. DRIO, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in LifeSci Partners Corporate Access Event

Posted on January 5, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the 10th annual LifeSci Partners Corporate Access Event. As part of the company’s participation, AzurRx president and CEO James Sapirstein will present a … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX, MissionIRNewsBreaks | Leave a comment

Knightscope Introduces App to Help Identify Locations Where Autonomous Public Safety Robots Can Protect and Serve

Posted on January 4, 2021 by MissionIR

Autonomous Security Robot (ASR) developer Knightscope has deployed its high-tech sentries at institutions including hospitals, universities, Fortune 1000 companies and even on behalf of NBA team the Sacramento Kings Knightscope counts law enforcement personnel and private security industry directors among … Continue reading →

Posted in Knightscope, Inc. | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shares Objectives for Berubicin Phase 2 Trial

Posted on January 4, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently hosted a webinar to discuss the clinical design for its upcoming Phase 2 … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment